ABCD Announcements Archive
Dr. Dipesh Patel
Do you know an outstanding Educator in UK or Ireland?
Do you work with an exceptional diabetes healthcare professional who deserves to be recognised?
Are you aware of a diabetes hero (non-…
Dr. Dipesh Patel
Hosted by The Royal Society of Medicine
What’s new in endocrinology and diabetes: The effects of COVID-19
Wednesday 8 September to Friday 10 September 2021 from 4:30pm to 6:05pm BST
During this…
Professor Gerry Rayman
Every year over 300,000 elective operations take place on people with diabetes. Getting it Right First Time (GIRFT) has worked together with a small group of clinicians, made up of doctors,…
Dr. Sufyan Hussain
Overview of hybrid closed loops - key concepts, options available and choosing the right system
Wednesday 21st July 2021, 17.00 - 18.30
The DTN-UK are delighted to launch a three-part webinar series…
Dr. Dipesh Patel
Diabetes UK have announced the launch of their new campaign Diabetes is Serious, which aims to highlight the learnings and insights from their Diabetes Can't Wait report about the experiences…
Professor Jonathan Valabhji
A new 12 week NHS Digital Weight Management Programme (DWMP) has formally launched today for people living with obesity and diabetes or hypertension. Referrals are via general practice. The slide…
Professor Thozhukat Sathyapalan
Users of the FreeStyle Libre system in the UK show improvements in glycaemic control and awareness of hypoglycaemia which are associated with improvement in diabetes-related distress, according to a…
Dr. Bob Ryder
Today at ADA 2021, ABCD is pleased to announce the launch of the ABCD nationwide oral semaglutide audit. As you will know, the clinical trials with semaglutide suggest that it may be more effective…
King's College London are seeking applications for the prestigious RD Lawrence Chair. For further information please see the detailed advertisement.
Dr. Thomas Crabtree
The ABCD Empagliflozin audit has provided valuable insights into empagliflozin use in UK based real-world practice. Additionally, data from the other SGLT2 audit programmes has demonstrated…
Dr. Bob Ryder
The ABCD Empagliflozin audit has provided valuable insights into empagliflozin use in UK based real-world practice. Additionally, data from the other SGLT2 audit programmes has demonstrated…
Dr. Thomas Crabtree
We are pleased to be presenting our first analysis from the ABCD Semaglutide audit at the American Diabetes Association Scientific Session virtual session this weekend.
Our real-world cohort was…
